関連する実験動画
Updated: Jun 15, 2026

08:45
Assessing Cellular Target Engagement by SHP2 (PTPN11) Phosphatase Inhibitors
Published on: July 17, 2020
M. tuberculosisのタンパク質チロシンフォスファタゼ PtpB 蓋ドメインによるダイナミックな活性部位保護
E Megan Flynn1, Jeffrey A Hanson, Tom Alber
1Department of Molecular and Biology and QB3 Institute, University of California, Berkeley, California 94720, USA.
Journal of the American Chemical Society
|March 17, 2010
まとめ
Mycobacterium tuberculosis protein tyrosine phosphatase PtpBは,ダイナミックな蓋のメカニズムを使用して酸化ストレスに抵抗する. この蓋は急速に開閉し,活性部位を保護し,不活性化を遅らせます.
科学分野:
- バイオケミストリー バイオケミストリー
- 分子生物学は分子生物学である.
- 構造生物学 構造生物学とは
背景:
- Mycobacterium tuberculosis protein tyrosine phosphatase PtpB (PtpB) は,宿主マクロファージ内の酸化ストレスに対する抵抗性を表しています.
- この酸化抵抗の背後にあるメカニズムは完全に理解されていません.
- 以前の結晶構造は,PtpBが活性部位を覆う2つのヘリクスの蓋を持っていることを示した.
研究 の 目的:
- PtpB蓋のダイナミクスと酸化抵抗におけるその役割を調査する.
- 酸化条件へのPtpBの適応の分子メカニズムを解明する.
主な方法:
- 単一分子フォスター型共振エネルギー伝送 (smFRET) は,PtpBの蓋を形成する2つのヘリクスの動態を研究するために使用されました.
- オープニングとクロージングレートの測定が行われました.
- 酸化不活性化率に対する溶媒粘度 (グリセロールとPEG8000) の影響を評価した.
主要な成果:
- PtpB 蓋の自発的な開閉移行の直接的な証拠が得られた.
- 蓋の閉ざされた形状は,約3:1で好まれた.
- 2つの蓋のヘリクスは,異なる開閉速度で,非同期的に動きます.
- Lidダイナミクスは,酸化不活性化の遅い速度を定量的に説明しました.
- グリセロールによる溶媒の粘度増加,PEG8000ではないが,オープンコンフォマー群を増やすことで酸化不活性化を加速した.
結論:
- PtpBの蓋は,急速な形状ゲーティングを示し,可逆的な物理的封鎖として作用します.
- このダイナミックな蓋のメカニズムは,活性部位を一時的にマスクし,酸化不活性化を遅らせます.
- PtpBの酸化ストレスへの適応には,その活性部位の膜の保護的構造的柔軟性が含まれています.
関連する概念動画
Pulmonary Tuberculosis IV
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Tuberculosis
Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...
The JAK-STAT Signaling Pathway
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
Pulmonary Tuberculosis II
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
PI3K/mTOR/AKT Signaling Pathway
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a rapamycin-insensitive companion...
Pulmonary Tuberculosis V
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...

